Ashay Jain
Overview
Explore the profile of Ashay Jain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar Behera J, Kumar S, Sharma R, Jain A, Kumar Garg N, Khopade A, et al.
Adv Drug Deliv Rev
. 2023 Dec;
205:115174.
PMID: 38161056
Onychomycosis continues to be the most challenging disease condition for pharmaceutical scientists to develop an effective drug delivery system. Treatment challenges lie in incomplete cure and high relapse rate. Present...
2.
Jain A, Sharma G, Thakur K, Raza K, Shivhare U, Ghoshal G, et al.
AAPS PharmSciTech
. 2019 Feb;
20(3):100.
PMID: 30721373
Beta-carotene (BC), a red-colored pigment found in plants and animals, is one of the most extensively investigated carotenoids due to its provitamin-A, antioxidant, and anticancer properties. The anticancer activity of...
3.
Jain A, Sharma G, Ghoshal G, Kesharwani P, Singh B, Shivhare U, et al.
Int J Pharm
. 2018 May;
546(1-2):97-105.
PMID: 29715533
The work entails a novel strategy of formulating the lycopene loaded whey protein isolate nanoparticles (LYC-WPI-NPs) solely using the rational blend of biomacromolecule without using equipment-intensive techniques. The LYC-WPI-NPs were...
4.
Thakur K, Sharma G, Singh B, Jain A, Tyagi R, Chhibber S, et al.
Nanomedicine (Lond)
. 2018 Mar;
13(8):825-847.
PMID: 29528278
Aim: The aim of the current study was to investigate the therapeutic efficacy of cationic-charged bilayered nanoemulsion for topical delivery of fusidic acid in eradicating methicillin-resistant Staphylococcus aureus (MRSA) bacterial...
5.
Jain A, Sharma G, Kushwah V, Ghoshal G, Jain A, Singh B, et al.
Artif Cells Nanomed Biotechnol
. 2018 Jan;
46(sup1):402-412.
PMID: 29361842
Beta carotene (βC) loaded nanoparticles of zein (βC-NPs) were developed using modified phase separation technique. βC-NPs were prepared using different zein concentration and optimized formulation was selected on the basis...
6.
Khurana R, Jain A, Jain A, Sharma T, Singh B, Kesharwani P
Drug Discov Today
. 2018 Jan;
23(4):763-770.
PMID: 29317341
Several randomized clinical trials have divulged that administration of antioxidants during chemotherapy decreases the effectiveness of treatment. Hence, the characteristic feature of this article is extensive assessment of putative benefits...
7.
Jain A, Jain A, Parajuli P, Mishra V, Ghoshal G, Singh B, et al.
Drug Discov Today
. 2017 Nov;
23(5):960-973.
PMID: 29129804
Galactosylated nanocarriers have recently emerged as viable and versatile tools to deliver drugs at an optimal rate specifically to their target tissues or cells, thus maximizing their therapeutic benefits while...
8.
Jain A, Sharma G, Kushwah V, Garg N, Kesharwani P, Ghoshal G, et al.
Nanomedicine (Lond)
. 2017 Jul;
12(15):1851-1872.
PMID: 28703643
Aim: This work was intended to investigate the targeting potential of fructose-tethered lipid-polymeric hybrid nanoparticles (F-BC-MTX-LPHNPs) co-loaded with beta carotene (BC) and methotrexate (MTX) in breast cancer therapeutics and find...
9.
Thakur D, Jain A, Ghoshal G, Shivhare U, Katare O
AAPS PharmSciTech
. 2017 May;
18(5):1447-1459.
PMID: 28550604
β-Carotene, abundant majorly in carrot, pink guava yams, spinach, kale, sweet potato, and palm oil, is an important nutrient for human health due to its scavenging action upon reactive free...
10.
Garg N, Tyagi R, Sharma G, Jain A, Singh B, Jain S, et al.
Mol Pharm
. 2017 Apr;
14(6):1883-1897.
PMID: 28402673
The present study was aimed to coencapsulate methotrexate (MTX) and aceclofenac (ACL) in fucose anchored lipid-polymer hybrid nanoparticles (Fu-LPHNPs) to achieve target specific and controlled delivery for developing therapeutic interventions...